Matching articles for "nemolizumab"
Issue 1749 · March 2, 2026
Drugs for Atopic Dermatitis

Atopic dermatitis (AD), also known as eczema, is frequently associated with other atopic disorders such as allergic rhinitis, asthma, and food allergy. It commonly presents in infancy and early childhood and…

Med Lett Drugs Ther. 2026 Mar 2; 68(1749):33-40 doi:10.58347/tml.2026.1749a
Atopic dermatitis (AD), also known as eczema, is frequently associated with other atopic disorders such as allergic rhinitis, asthma, and food allergy. It commonly presents in infancy and early childhood and has a relapsing course, often improving by adolescence, but sometimes persisting into or first appearing in adulthood or even old age. Guidelines for the treatment of AD have recently been updated.
Issue 1749 · March 2, 2026 Free
Comparison Chart: Interleukin (IL) Antagonists and Oral JAK Inhibitors for Moderate to Severe Atopic Dermatitis (online only)

View the Comparison Chart: Interleukin (IL) Antagonists and Oral JAK Inhibitors for Moderate to Severe Atopic Dermatitis

Med Lett Drugs Ther. 2026 Mar 2; 68(1749):e43-4 doi:10.58347/tml.2026.1749e
View the Comparison Chart: Interleukin (IL) Antagonists and Oral JAK Inhibitors for Moderate to Severe Atopic Dermatitis
Issue 1722 · February 17, 2025
Nemolizumab (Nemluvio) for Atopic Dermatitis

Nemolizumab ( Nemluvio – Galderma), a subcutaneously injected interleukin-31 (IL-31) receptor antagonist, has been approved by the FDA for use in combination with topical corticosteroids and/or calcineurin…

Med Lett Drugs Ther. 2025 Feb 17; 67(1722):25-7 doi:10.58347/tml.2025.1722a
Nemolizumab ( Nemluvio – Galderma), a subcutaneously injected interleukin-31 (IL-31) receptor antagonist, has been approved by the FDA for use in combination with topical corticosteroids and/or calcineurin inhibitors for treatment of moderate to severe atopic dermatitis in patients ≥12 years old whose disease is not adequately controlled with topical prescription drugs. It is the first IL-31 receptor antagonist to be approved in the US for this indication. Nemolizumab was approved earlier for treatment of prurigo nodularis in adults.
Issue 1722 · February 17, 2025 Free
Comparison Chart: Interleukin (IL) Receptor Antagonists for Atopic Dermatitis (online only)

View the Comparison Chart: Interleukin (IL) Receptor Antagonists for Atopic Dermatitis

Med Lett Drugs Ther. 2025 Feb 17; 67(1722):e1 doi:10.58347/tml.2025.1722f
View the Comparison Chart: Interleukin (IL) Receptor Antagonists for Atopic Dermatitis
Issue 1600 · June 15, 2020
Drugs for Atopic Dermatitis

Atopic dermatitis (AD; also known as eczema) is frequently associated with other atopic disorders such as allergic rhinitis, asthma, and food allergy. It commonly presents in infancy and early childhood and…

Med Lett Drugs Ther. 2020 Jun 15; 62(1600):89-96
Atopic dermatitis (AD; also known as eczema) is frequently associated with other atopic disorders such as allergic rhinitis, asthma, and food allergy. It commonly presents in infancy and early childhood and has a relapsing course, often improving by adolescence, but sometimes persisting into (or first appearing in) adulthood or even old age.